FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/05/2024
Back to search
Official data from USPTO
ROHTONITTEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
02/05/2024
Trademark type
Combined
Nice classes
5
Filing date
09/08/2021
Registration date
10/17/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2023
Last transaction
10/17/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
JP
Examiner
CALLOWAY, CHRISTINA DENISE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized blue wording "ROHTONITTEN". The color white represents background and/or transparent areas and is not a feature of the mark.
Holders and representatives
Holders
Rohto Pharmaceutical Co., Ltd.
Representatives
Sandra Epp Ryan Hamre, Schumann, Mueller & Larson, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
In-vitro diagnostic drugs; eye wash bactericides; medicated eye ointments; contact lens cleaning preparations; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for treatment of eye disease; pharmaceutical preparations for use in eye injections; pharmaceutical preparations for treatment of pinguecula ; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of eratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Analgesics; antipyretic preparations; antibiotics; athletes' foot preparations; medicinal drinks; medicinal hair growth preparations; motion sickness treatment preparations; pharmaceutical preparations for treating diabetes; preparations for treating colds; reagent paper for medical purposes; collyrium; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babiesliquid formula milk for babies; food for babies; dietary supplements; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; capsules sold empty for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental porcelainmaterials; dental impression materials; dental composite materials; diapersincontinence diapersbaby diapers; infant diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for humans; semen for artificial insemination
Publications
History of USPTO decisions and trademark events.
34 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/18/2024
FIMP
FINAL DISPOSITION PROCESSED
01/18/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2023
GPNX
NOTIFICATION PROCESSED BY IB
08/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2023
PUBO
PUBLISHED FOR OPPOSITION
08/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/26/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/26/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/26/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/26/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/26/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/17/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/17/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/29/2022
GNFR
FINAL REFUSAL E-MAILED
11/29/2022
CNFR
FINAL REFUSAL WRITTEN
11/29/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/01/2022
RFNT
REFUSAL PROCESSED BY IB
07/19/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/30/2022
RFRR
REFUSAL PROCESSED BY MPU
06/30/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/16/2022
CNRT
NON-FINAL ACTION WRITTEN
06/15/2022
DOCK
ASSIGNED TO EXAMINER
06/13/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/21/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/17/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/16/2021
Continuous trademark protection
Get notified about every new filing that threatens ROHTONITTEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.